During the last session, Annovis Bio Inc (NYSE:ANVS)’s traded shares were 1.43 million, with the beta value of the company hitting 1.54. At the end of the trading day, the stock’s price was $2.43, reflecting an intraday gain of 19.12% or $0.39. The 52-week high for the ANVS share is $17.88, that puts it down -635.8 from that peak though still a striking 54.32% gain since the share price plummeted to a 52-week low of $1.11. The company’s market capitalization is $47.35M, and the average trade volume was 354.92K shares over the past three months.
Annovis Bio Inc (ANVS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.50. ANVS has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Annovis Bio Inc (NYSE:ANVS) trade information
Annovis Bio Inc (ANVS) registered a 19.12% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 19.12% in intraday trading to $2.43, hitting a weekly high. The stock’s 5-day price performance is 13.55%, and it has moved by 56.77% in 30 days. Based on these gigs, the overall price performance for the year is -65.68%.
The consensus price target of analysts on Wall Street is $26, which implies an increase of 90.65% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $21 and $30 respectively. As a result, ANVS is trading at a discount of -1134.57% off the target high and -764.2% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -73.95%. While earnings are projected to return 29.95% in 2025, the next five years will return 18.86% per annum.
ANVS Dividends
Annovis Bio Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Annovis Bio Inc (NYSE:ANVS)’s Major holders
The next largest institutional holding, with 0.36 million shares, is of VANGUARD GROUP INC’s that is approximately 3.1956% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $2.08 million.
Also, the Mutual Funds coming in first place with the largest holdings of Annovis Bio Inc (ANVS) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 330.51 shares. This amounts to just over 1.70 percent of the company’s overall shares, with a $0.8 million market value. The same data shows that the other fund manager holds slightly less at 129.74, or about 0.67% of the stock, which is worth about $0.32 million.
